Startups
Woolly Mammoth, Dodo Get Another Shot as Startup Raises $200 Million
Colossal Biosciences, now valued at $10.2 billion, aims to produce a mammoth by 2028.
A rendering of a woolly mammoth.
Photographer: Leonello Calvetti/Science Photo/Getty ImagesThis article is for subscribers only.
A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.
Colossal Biosciences Inc. is using DNA and genomics to try to resurrect the dodo, Tasmanian tiger and the woolly mammoth. Co-founder and Chief Executive Officer Ben Lamm says the company is on track to produce a woolly mammoth calf born to a surrogate elephant mother by late 2028.